Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Endocrine Disruptor Regs In Limbo; Parliament Urges 'Suspected' Category

Executive Summary

The European Commission is mulling directives from Parliament regarding its criteria for identifying endocrine disruptors, following the latter's rejection of a related EC draft regulation in October. Among shortcomings cited by lawmakers is the absence of a "suspected" ED category, which would be "extremely relevant" in the cosmetics sector, they say.

Advertisement

Related Content

EU Endocrine Disruptor Guidance Open For Comments; Benefit Cosmetics Recall; More News In Brief
EU Eyeing Carcinogen Tag For Titanium Dioxide Under CLP Reg; Why It Matters For Cosmetics
EC Releases Endocrine-Disruptor Criteria, Drawing Heavily On WHO Definitions

Topics

Advertisement
UsernamePublicRestriction

Register

RS121323

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel